APA (7th ed.) Citation

Wiltshire, H. R., Kilpatrick, G. J., Tilbrook, G. S., & Borkett, K. M. (2012). A Placebo- and Midazolam-Controlled Phase I Single Ascending-Dose Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Remimazolam (CNS 7056): Part II. Population Pharmacokinetic and Pharmacodynamic Modeling and Simulation. Anesthesia and analgesia, 115(2), 284-296. https://doi.org/10.1213/ANE.0b013e318241f68a

Chicago Style (17th ed.) Citation

Wiltshire, Hugh R., Gavin J. Kilpatrick, Gary S. Tilbrook, and Keith M. Borkett. "A Placebo- and Midazolam-Controlled Phase I Single Ascending-Dose Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Remimazolam (CNS 7056): Part II. Population Pharmacokinetic and Pharmacodynamic Modeling and Simulation." Anesthesia and Analgesia 115, no. 2 (2012): 284-296. https://doi.org/10.1213/ANE.0b013e318241f68a.

MLA (9th ed.) Citation

Wiltshire, Hugh R., et al. "A Placebo- and Midazolam-Controlled Phase I Single Ascending-Dose Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Remimazolam (CNS 7056): Part II. Population Pharmacokinetic and Pharmacodynamic Modeling and Simulation." Anesthesia and Analgesia, vol. 115, no. 2, 2012, pp. 284-296, https://doi.org/10.1213/ANE.0b013e318241f68a.